A Study to Assess the Bioavailability of a New Tablet Formulation of Minzasolmin and the Effect of Food in Healthy Participants

NCT06533475 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants

Interventions

DRUG: Minzasolmin tablet formulation under fasting condition
DRUG: Minzasolmin Granules in capsule under fasting condition
DRUG: Minzasolmin tablet formulation under fed condition

Sponsor

UCB Biopharma SRL